In April 2021, a provision in the 21st Century Cures act took effect which required that all medical test results be released to a patient's electronic medical record as soon as they become available.
A study from PreciseDx showed that its artificial-intelligence-guided pathology test could help predict a patient’s chances of their breast cancer returning on par with a leading genomic approach.
The companies are codeveloping a test that leverages Veravas’ proprietary VeraBIND ™ technology with Phanes’ biological intellectual property on tau pathology to detect active disease by ...